This inventor holds 4 USPTO granted patents. Top assignee: Johns Hopkins University. Active years: 1988-2018.
Company Filing History:
Years Active: 1988-2018
Title: Michael Edidin: Innovator in Cellular Selectivity and Drug Delivery
Introduction
Michael Edidin is a prominent inventor based in Baltimore, MD (US), known for his significant contributions to the fields of cellular selectivity and drug delivery systems. With a total of 4 patents to his name, Edidin has made strides in enhancing the effectiveness of targeted therapies.
Latest Patents
Among his latest patents is a groundbreaking method titled "Methods and compositions for enhanced cellular selectivity using nanocarrier-associated ligands." This invention provides innovative methods and compositions for the activation of clustered receptors on target cells, particularly focusing on antigen-experienced T cells using nanocarrier-associated antibodies. Another notable patent is the "Protein label and drug delivery system," which describes a bridging molecule that carries a drug or a label, such as a fluorophore. This bridging molecule is reactive with sulfhydryl groups formed by the reduction of disulfide bonds in proteins, showcasing Edidin's expertise in drug delivery mechanisms.
Career Highlights
Michael Edidin is affiliated with Johns Hopkins University, where he continues to advance research in his field. His work has not only contributed to scientific knowledge but has also paved the way for practical applications in medicine.
Collaborations
Throughout his career, Edidin has collaborated with esteemed colleagues, including Beverly S Packard and Akira Komoriya, further enhancing the impact of his research.
Conclusion
Michael Edidin's innovative work in cellular selectivity and drug delivery systems exemplifies the importance of research in advancing medical science. His contributions continue to influence the development of targeted therapies, making a significant impact in the field.